• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan+
  • Wellness
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Career
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan+
  • Wellness
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Career
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home StudyGraphics

#VisualAbstract Glucagon-Like Peptide-1 Receptor Agonists are Protecting in Type 2 Diabetes Mellitus Patients

byAngel GaoandAlisha Yi
August 22, 2024
in StudyGraphics
Reading Time: 1 min read
0
Share on FacebookShare on Twitter

Click here to read this article in JAMA Internal Medicine. 

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Utilization of an early-life risk factor score to determine later life type 2 diabetes risk

Exenatide does not slow Parkinson’s disease progression compared to placebo

#VisualAbstract: Increased Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy Risk Among Patients with Diabetes

Tags: diabetesdiabetes miellitusdiscontinuationDPP-4 inhibitorsglp-1GLP-1 receptor agonistGLP-1 receptor agonistshyperkalemiaT2DM
Previous Post

#VisualAbstract: Impact of a community health worker led intervention for improved blood pressure control

Next Post

Impact of dialysis on survival and home time among older adults with chronic kidney failure

RelatedReports

Intrapartum serum prolactin may predict risk of postpartum diabetes
Cardiology

Utilization of an early-life risk factor score to determine later life type 2 diabetes risk

April 29, 2025
Levodopa for Parkinson’s disease more effective than newer generation therapies
Chronic Disease

Exenatide does not slow Parkinson’s disease progression compared to placebo

April 25, 2025
#VisualAbstract: Increased Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy Risk Among Patients with Diabetes
StudyGraphics

#VisualAbstract: Increased Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy Risk Among Patients with Diabetes

April 18, 2025
Food environment associated with gestational diabetes
Chronic Disease

Spot capillary HbA1c testing may have a role in early detection of type 2 diabetes

April 10, 2025
Next Post
Poor olfaction linked to increased mortality in older adults

Impact of dialysis on survival and home time among older adults with chronic kidney failure

General anesthesia exposure in infants not linked to impaired cognitive development

2 Minute Medicine Rewind August 26, 2024

#VisualAbstract: In Utero Exposure to Buprenorphine and Naloxone has Similar and More Favourable Outcomes Buprenorphine Alone

#VisualAbstract: In Utero Exposure to Buprenorphine and Naloxone has Similar and More Favourable Outcomes Buprenorphine Alone

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • No difference between pharmacologic treatments in age-related macular degeneration risk reduction
  • Vaccinations may be associated with small but temporary changes in menstrual cycle length
  • The Scan by 2 Minute Medicine®: Climate-Driven Crises, Serena’s Mental Fitness Revolution, Superhuman Immunity, and Healthcare on Strike
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Career
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.